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Abstract 
AIM: To study clinical and epidemiological parameters of patients undergoing percutaneous coronary intervention 
(PCI) and to follow them up for understanding the outcomes of the procedure. 
MATERIAL AND METHODS: This is a retrospective data analysis of 862 patients who underwent PCI from 
January 2016 to November 2017 
RESULTS: Out of 862 patients, 611 (70.88%) were male & 251 (29.12%) were female, with the mean age being 
55. 243 (28.19%) were diabetic, 470 (54.52%) were hypertensive, 158 (18.32%) patients were tobacco chewer, 
215 (24.92%) were smokers and 111 (12.87%) were alcoholic. 636 (73.78%) patients had STEMI, 153 (17.74%) 
had NSTE-ACS, 61 (7.07%) had CSA.578 (67.05%) were SVD, 262 (30.39%) were DVD and 19 (2.20%) were 
TVD. Out of SVD, 350 (60.55%) patients had LAD involvement and among DVD patients, LAD and RCA were 
most commonly involved in 107 (40.83%) patients. On follow-up of mean 604.42 days (minimum 236 days, 
maximum 909 days), 2 (0.23%) episodes of subacute stent thrombosis occurred and 11 (1.27%) patients had ISR 
but no mortality was reported. 
CONCLUSION: The study shows affection of young population predominately and genders inequality, suggesting 
primarily male disease. PCI is often sought in ACS and CSA is predominately treated medically. Thrombolysis 
remains the first treatment received by STEMI patients. SVD is the most common angiographic diagnosis with 
LAD predominately affected vessel. This real world-data on clopidogrel with aspirin as dual antiplatelet therapy 
and second-generation stent shows negligible event of stent thrombosis and ISR. 
LIMITATION: Due to non-invasive follow-up, the exact amount of stent restenosis cannot be calculated.  
IMPACT ON DAILY PRACTICE: This real world-data on clopidogrel with aspirin as dual antiplatelet therapy and 
second-generation stent shows negligible event of stent thrombosis and ISR. This can help reduce the cost 
burden on society and help better distribution of health budget. 
 
 
 
 
 
 
Introduction 
 
Percutaneous coronary intervention (PCI) is 
the cornerstone in the treatment of acute coronary 
syndrome (ACS). PCI is an evolving science and 
outcomes of which depend on characteristics of the 
individual patient, operator experience, availability of 
newer and more sophisticated hardware, 
improvement in our understanding of the science of 
atherosclerosis, etc. Since the first balloon angioplasty 
done by Dr Andreas Gruntzig in 1987, the art of PCI 
has changed a lot. Balloon angioplasty evolved into 
angioplasty with stenting and from bare-metal stents 
(BMS) to eluting drug stents (DES). DES is constantly 
changing from the type of drug being used to the 
amount of metal, the thickness of struts, platform 
design, etc. The stent classification system developed 
by Dr Sundeep Mishra helps in understanding the 
importance of newer stent with newer drugs [1]. Also, 
at the same time when stents are undergoing 
evolution, newer antiplatelet drugs with improved 
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efficacy and potency are being launched. American 
college of cardiology has put newer antiplatelets 
ticagrelor and prasugrel as first-line antiplatelet for 
patients undergoing PCI [2]. But the real-world data is 
quite different from trials data which are done in a 
controlled environment. Hence, came the concept of 
the registry to maintain real-world data which is 
usually free from pharmaceutical industry bias. 
Reviewing the registry helps us understand the real-
world scenario and analysing it makes one more 
competent in dealing with patients in one’s locality. 
Objectives: - To understand the age-wise & 
gender-wise distribution of patients; - To know the 
percentage prevalence of risk factors viz. diabetes 
mellitus, hypertension, smoking, tobacco chewing and 
alcohol intake among patients requiring PCI; - To 
know the prevalence of ST-elevation myocardial 
infarction (STEMI), non-ST elevation acute coronary 
syndrome (NSTE-ACS) & chronic stable angina (CSA) 
among patients who underwent PCI in real-world 
scenario; - To study the distribution of left ventricular 
ejection fraction (LVEF) among patients undergoing 
PCI; - To learn about the incidence of involvement of 
type of coronary artery and dimensions of coronary 
stents required for PCI; - To follow-up the cohort to 
calculate incidence of stent thrombosis, in-stent 
restenosis, other complications or deaths. 
 
 
Methods 
 
This is retrospective data analysis of 862 
patients who underwent PCI from January 2016 to 
November 2017 at the department of cardiology in our 
institute under Mahatma Jyotiba Phule Jan Arogya 
Yojana (MJPJAY). This cohort was followed up in July 
2018 with a mean duration of 604.4 ± 161.4 days.  
Exclusion criteria: Patients who were in 
cardiogenic shock or required vasopressors or 
support ventilation before or at the time of PCI were 
excluded from the study. 
Age-wise distribution is done as follows: A) 
teenage – defined as age between 13 years to 19 
years; B) very young (3) – defined as age from 20 
years to 35 years; C) young (4) – defined as age from 
36 years to 55 years; D) peri-retirement – defined as 
age from 56 years to 64 years; and E) elderly [5], [6] – 
defined as age more than or equal to 65 years. Risk 
factors considered in the study were diabetes mellitus, 
hypertension, smoking, tobacco chewing or alcohol 
intake. Diabetes mellitus was defined in the study as 
per WHO guidelines, 2006 [7]. Hypertension was 
defined in the study as those patients who required 
pharmacologic therapy for hypertension as per the 
Eighth Joint National Committee (JNC 8) guidelines 
[8]. The individuals were classified as “chewing 
tobacco” if the patient or his/her relatives answered 
“yes” to the question of chewing tobacco. Similarly, 
individuals were categorised as “smokers” if the 
patient or his/her relatives answered, “yes” to the 
question of “smoking tobacco” [9].  
Table 1: Summary of variables 
Variable Observation 
(n = 862) 
Male 611 (70.88%) 
Female 251 (29.12%) 
Age  
Teenage (< 20) 1 (0.11%) 
Very Young (20 to ≤ 35) 30 (3.48%) 
Young (35 to ≤ 55) 405 (46.98%) 
Peri-retirement (56 to 64) 222 (25.75%) 
Elderly (≥ 65) 204 (23.66%) 
Diabetes 243 (28.19%) 
Hypertension 470 (54.52%) 
Tobacco chewer 158 (18.32%) 
Smoker 215 (24.92%) 
Alcoholic 111 (12.87%) 
STEMI 636 (73.78%) 
NSTE-ACS 153 (17.74%) 
CSA 61 (7.07%) 
Thrombolysis 302 (47.48%) 
PAMI 3 
AWMI 384 (60.37%) 
IWMI 262 (41.19%) 
CTO 47 (5.45%) 
SVD 578 (67.05%) 
DVD 262 (30.39%) 
TVD 19 (2.20%) 
LVEF  
≤ 30 158 (18.32%) 
30-45 239 (27.72%) 
46-60 233 (27.03%) 
≥ 60 232 (26.91%) 
Follow-up means 604.42 days 
Local complication 9 (1.04%) 
Stent thrombosis 2 (0.23%) 
ISR 11 (1.27%) 
 
In the same way, alcohol intake was based on 
response either “yes” or “no” of the question to 
patients or their relatives when asked about alcohol 
drinking habit [10]. Acute coronary syndrome either 
STEMI [11] or NSTE-ACS [12] and chronic stable 
angina [13] were defined by the American College of 
Cardiology guidelines (ACC). Thrombolysis, whether 
done in our institute or patient, was thrombolysis at 
other centre and referred for further management was 
defined thrombolysis irrespective of thrombolytic 
agent used. Primary angioplasty in myocardial 
infarction (PAMI) was defined as when the patient 
presented within 6 hours of the onset of symptoms of 
ACS and was taken for PCI directly. STEMI was 
subclassified into anterior wall myocardial infarction 
(AWMI) or inferior wall myocardial infarction (IWMI) 
depending upon whether ST elevation is recorded in 
anterior chest lead or inferior leads respectively. 
Chronic total occlusion (CTO) of the coronary artery 
was defined as at least 3 months of total occlusion of 
coronary artery or infarct-related artery total occlusion 
when the primary event was recorded 3 months 
earlier plus the use of guide-wire for angioplasty with 
a tipping load of more than 4 gm. Single vessel 
disease (SVD) was the involvement of only one 
coronary artery with a significant lesion that requires 
intervention, while double vessel disease (DVD) was 
when two coronary arteries required intervention. 
Similarly, triple vessel disease (TVD) was defined 
when all the three left anterior descending (LAD), left 
circumflex (LCX) and right coronary artery (RCA) 
required stenting during PCI.  
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Stent details 
The two stents that belong to second-
generation DES used during this period for PCI at the 
department were as follows: 1) ProNOVA (Vascular 
concepts Ltd, India) and 2) Endeavor (Medtronic, 
United States of America) 
 
Antiplatelet details 
A loading dose of 300 mg of aspirin with 600 
mg of clopidogrel was used in all patients analysed in 
the study and dual antiplatelet therapy with aspirin 75 
mg and clopidogrel 75 mg once daily post PCI were 
prescribed. Stent thrombosis was defined as per 
timings and definition of academic research 
consortium [14]. Restenosis was defined in this study 
as more than 50% diameter stenosis in the patient 
who presents with either ACS or refractory symptoms 
despite optimal anti-anginal drugs. Local 
complications considered were pseudoaneurysm, 
hematoma, arterio-venous fistula. Deaths any 
reported during this period were classified into cardiac 
or non-cardiac based on verbal autopsy. 
Data regarding all clinical and epidemiological 
variables were obtained from MJPJAY database of 
the hospital record. Follow-up of all patients that 
underwent PCI under MJPJAY scheme at our hospital 
excluding those mentioned in exclusion criteria was 
done in July 2018 at one point in time in a cross-
sectional manner and any event in the past from the 
date of PCI was recorded as per protocol. Individual 
characteristic was expressed using the percentage of 
the total event.  
 
 
Results 
 
Out of 862 patients, 611 (70.88%) were male, 
and 251 (29.12%) were female. Patients’ age was 
uniformly distributed from 18 years of age to 85 years 
of age as shown in Table 2, with both median age and 
mean age being 55. Two hundred forty-three 
(28.19%) were diabetic and 470 (54.52%) were 
hypertensive. 158 (18.32%) patients were tobacco 
chewer, 215 (24.92%) were smokers and 111 
(12.87%) were alcoholic. Six hundred thirty-six 
(73.78%) patients had STEMI, 153 (17.74%) had 
NSTE-ACS, 61 (7.07%) had CSA.  
Table 2: Age-wise distribution 
Age Number Percentage 
Teenage (< 20) 1 0.11 
Very Young (20 to ≤ 35) 30 3.48 
Young (35 to ≤ 55) 405 46.98 
Peri-retirement (56 to 64) 222 25.75 
Elderly (≥ 65) 204 23.66 
 
Out of 636 patients with STEMI, 302 patients 
were thrombolysis (47.48%) before being referred to 
our centre and only 3 patients received PAMI. Also, 
out of STEMI patients, AWMI has diagnosed in 384 
(60.37%) patients and IWMI in 262 (41.19%) patients. 
Table 3: Distribution according to LVEF 
LVEF Number Percentage 
=<30 158 18.32 
30-45 239 27.72 
46-60 233 27.03 
>=60 232 26.91 
 
Table 3 shows the distribution of patients 
according to LVEF. Forty-seven (5.45%) patients were 
CTO, out which 5 (10.63%) attempts failed. As per 
this PCI registry, 578 (67.05%) were SVD, 262 
(30.39%) were DVD and 19 (2.20%) were TVD. Out of 
SVD, 350 (60.55%) patients had LAD involvement 
and among DVD patients, LAD and RCA were most 
commonly involved in 107 (40.83%) patients. Five 
hundred seventy-seven times LAD PCI was done with 
average stent diameter of 2.97 mm and length of 
25.68 mm, 186 times LCX PCI was done with average 
stent diameter of 2.86 mm and length of 22.84 mm 
and 327 times RCA PCI was done with average stent 
diameter of 3.20 mm and length of 25.86 mm.  
On follow-up of mean 604.42 days (minimum 
236 days, maximum 909 days), 9 (1.04%) had a local 
complication which included one event of 
pseudoaneurysm and one event of radial artery 
thrombosis both of which were treated conservatively. 
There were 2 (0.23%) episodes of subacute stent 
thrombosis and 11 (1.27%) patients had ISR. 
 
 
Discussion 
 
The PCI registry data described here comes 
from patients who underwent PCI under the 
government health scheme for poor at 
academic/university government hospital. 
Epidemiology of ischemic heart disease in India is of 
concern. According to the present PCI registry almost 
of half of the population belonged to young age strata 
in contrast to United States National Cardiovascular 
Data Registry (US NCDR) database were mean age 
of PCI patients was 64.6 ± 12.1 and Japanese PCI 
registry where the mean age was 68.2 ± 9.8 [15]. The 
PURE study [16] describing epidemiological factors in 
the causation of cardiovascular diseases across 
different countries helps us understand these contrary 
findings in different countries. Diet, nutrition, the 
prevalence of diabetes & hypertension, access to 
healthcare facilities, funding for treatment of disease, 
etc. are the major determinants in making of this 
epidemiological picture. Also, as per the report of 
National Interventional Cardiology (NIC), 2011 for 
data on Indian coronary heart disease, 13.6% of 
patients were below 40 years of age [17]. Almost one 
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quarter i.e. 23.66% of patients undergoing PCI were 
elderly. This data shows a significant increase in the 
elderly population undergoing PCI for coronary artery 
disease but still, the young population is the majority 
affected. 70.88% of males are affected which is 
almost similar across the world statistics. More than 
half were hypertensive & more than one quarter were 
diabetic. Smoking, tobacco chewing and alcohol 
intake were involved as a risk factor in decreasing 
order. Three-fourth of patients undergoing PCI had 
STEMI which is way beyond described in US NCDR 
(14.44%), Japanese registry (23.01%) and NIC data 
(29.5%). Almost half of STEMI still undergo 
thrombolysis, and PAMI is occasional treatment 
received by the patient. Elective PCI for CSA is the 
least proportion of the population (~ 7%) while 22.3% 
population had CSA in NIC PIC registry, 31.69% in 
US NCDR and 50.59% in Japanese registry. Five 
percent CTO intervention is equitable to 2.2% CTO in 
NIC registry, 3.2% US NCDR and 6.4% in Japenese 
registry. Patients undergoing PCI had LVEF as 
normal, mild, moderate and severe left ventricular 
dysfunction approximately one quarter in each level. 
LAD is the most common coronary artery that requires 
stenting and LAD with RCA is the most common 
double vessel disease encountered. Incidence of stent 
thrombosis and ISR is negligible to make out any 
inferences.  
In conclusion, the epidemiological study of 
PCI data is of huge concern as it shows affection of 
young population predominately and gender 
inequality, suggesting primarily male disease. PCI is 
often sought in ACS and CSA is predominately 
treated medically. Thrombolysis remains the first 
treatment received by STEMI patients and PAMI is 
occasional. Single vessel disease is the most 
common form of coronary artery involvement with left 
anterior descending artery being the most commonly 
involved vessel. No mortality reported in 
approximately 2 years of follow-up with the negligible 
incidence of stent thrombosis or in-stent thrombosis 
shows the skill & knowledge of the operators of the 
centre and also presents real-world data for the 
second-generation stents and anti-platelet therapy 
used.  
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